Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to ...

Quest Diagnostics has rolled out an ultrasensitive blood test to monitor multiple myeloma treatment, potentially sparing patients from more invasive and costly bone marrow aspirations. | Quest ...

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the launch of a novel ...

Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions. The new method, known ...

Even though I have a degree in biology, I knew little about cancer – until life gave me a crash course. In 2019, while working on my master’s degree in Huntsville, I developed severe leg pain. At ...

A drug that kills cancer cells by puncturing them comes with an additional benefit: tests in mice suggest it reduces the growth of pain-sensing nerves around tumours ...

New immune roadmaps help physicians detect cancer recurrence early and customize treatments to the body’s defenses, providing right way for myeloma care.

GRAND RAPIDS, Mich. (WOOD) — July is Bone Cancer Awareness Month. Though it is rare, it can be difficult for those affected by it. Dr. Matthew Steensma, the chief for orthopedic oncology at Corewell ...

Cancer specialists have long known that anemia, caused by a lack of healthy red blood cells, can arise when cancer metastasizes to the bone, but it’s been unclear why. A research team led by Princeton ...